Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

被引:129
|
作者
Buchheit, Kathleen M. [1 ,3 ]
Cahill, Katherine N. [1 ,3 ]
Katz, Howard R. [1 ,3 ]
Murphy, Katherine C. [3 ]
Feng, Chunli [3 ]
Lee-Sarwar, Kathleen [1 ]
Lai, Juying [3 ]
Bhattacharyya, Neil [2 ,4 ]
Israel, Elliot [1 ,5 ]
Boyce, Joshua A. [1 ,3 ]
Laidlaw, Tanya M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Otolaryngol, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Pulm Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Aspirin-exacerbated respiratory disease; Samter triad; nasal polyps; thymic stromal lymphopoietin; prostaglandin D-2; cysteinyl leukotrienes; innate immunity; mast cells; eosinophils; INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; MAST-CELL; EOSINOPHILIC INFLAMMATION; CYSTEINYL LEUKOTRIENES; CHRONIC RHINOSINUSITIS; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; ASTHMATIC AIRWAYS; EXPRESSION;
D O I
10.1016/j.jaci.2015.10.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Prostaglandin (PG) D-2 is the dominant COX product of mast cells and is an effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease (AERD). Objective: We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells to generate PGD(2) and facilitate tissue eosinophilia and nasal polyposis in patients with AERD. Methods: Urinary eicosanoid levels were measured in aspirin-tolerant control subjects and patients with AERD. Nasal polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR, Western blotting, and immunohistochemistry. Human cord blood-and peripheral blood-derived mast cells were stimulated with TSLP in vitro to assess PGD(2) generation. Results: Urinary levels of a stable PGD(2) metabolite (uPGD-M) were 2-fold higher in patients with AERD relative to those in control subjects and increased further during aspirin-induced reactions. Peak uPGD-Mlevels during aspirin reactions correlated with reductions in blood eosinophil counts and lung function and increases in nasal congestion. Mast cells sorted from nasal polyps expressed PGD(2) synthase (hematopoietic PGD(2) synthase) mRNA at higher levels than did eosinophils from the same tissue. Whole nasal polyp TSLP mRNA expression correlated strongly with mRNA encoding hematopoietic PGD(2) synthase (r = .75), the mast cell-specific marker carboxypeptidase A3 (r = .74), and uPGD-M (r=0.74). Levels of the cleaved active form of TSLP were increased in nasal polyps from patients with AERD relative to those in aspirin-tolerant control subjects. Recombinant TSLP induced PGD(2) generation by cultured human mast cells. Conclusions: Our study demonstrates that mast cell-derived PGD(2) is a major effector of type 2 immune responses driven by TSLP and suggests that dysregulation of this innate system contributes significantly to the pathophysiology of AERD.
引用
收藏
页码:1566 / +
页数:16
相关论文
共 50 条
  • [1] Thymic Stromal Lymphopoietin Controls Prostaglandin D2 Generation in Aspirin-Exacerbated Respiratory Disease
    Buchheit, Kathleen M.
    Cahill, Katherine N.
    Katz, Howard
    Murphy, Katherine
    Feng, Chunli
    Lee-Sarwar, Kathleen
    Lai, Juying
    Bhattacharyya, Neil
    Israel, Elliot
    Boyce, Joshua A.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB198 - AB198
  • [2] Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease
    Feng, Xin
    Ramsden, Madison K.
    Negri, Julie
    Baker, Mary Grace
    Payne, Spencer C.
    Borish, Larry
    Steinke, John W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (04) : 1089 - U479
  • [3] Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease
    Cahill, Katherine N.
    Bensko, Jillian C.
    Boyce, Joshua A.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) : 245 - 252
  • [4] Platelets in patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    Boyce, Joshua A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (06) : 1407 - 1415
  • [5] Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    Cutler, Anya J.
    Kidder, Molly S.
    Liu, Tao
    Cardet, Juan Carlos
    Chhay, Heng
    Feng, Chunli
    Boyce, Joshua A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (06) : 1692 - +
  • [6] Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease
    Stevenson, Donald D.
    White, Andrew A.
    Simon, Ronald A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (06) : 1687 - 1688
  • [7] OUTCOMES OF PATIENTS WITH ASPIRIN-EXACERBATED RESPIRATORY DISEASE ON OMALIZUMAB
    Jean, T.
    Eng, V.
    Sheikh, J.
    Samant, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S14 - S14
  • [8] Tolerability to Etoricoxib in Patients With Aspirin-Exacerbated Respiratory Disease
    Koschel, D.
    Weber, C. Ninck
    Hoeffken, G.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2013, 23 (04) : 275 - 280
  • [9] Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (02) : 118 - 119
  • [10] The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)
    Spies, Jonas Willian
    Pereira Valera, Fabiana Cardoso
    Cordeiro, Daniel Loiola
    de Mendonca, Tas Nociti
    Junqueira Leite, Marcelo Goncalves
    Tamashiro, Edwin
    Arruda, Luiza Karla
    Anselmo-Lima, Wilma Terezinha
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2016, 82 (03) : 263 - 268